Clinical Study
The Effects of Continuous Blood Purification for SIRS/MODS Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
| Study or subgroup | CVVH | Control | | Risk ratio | Risk ratio | Events | Total | Events | Total | Weight | M-H, fixed, 95%Cl | M-H, fixed, 95%Cl |
| 5.1.1.MODS | | | | | | | | Sanchez Riera 1997 | 4 | 15 | 7 | 15 | 25.2% | 0.57 (0.21, 1.55) | Cole et al. 2002 [9] | 4 | 12 | 4 | 12 | 14.4% | 1.00 (0.32, 3.10) | Liu et al. 2003 [10] | 7 | 24 | 12 | 26 | 41.5% | 0.63 (0.30, 1.34) | Ding and Zhao 2007 [12] | 2 | 11 | 5 | 10 | 18.9% | 0.36 (0 09, 1.47) | Subtotal (95%Cl) | | 62 | | 63 | 100.0% | 0.62 (0.38, 1.01) | Total events | 17 | | 28 | | | | Heterogeneity: Chi-square = 1.27, df = 3 ( = 0.74); = 0% | | | | | | | Test for overall effect: = 1.91 ( = 0.06) | | | | | | | 5.1.2 SRS | | | | | | | Sander et al. 1997 [6] | 9 | 13 | 12 | 13 | 27.5% | 0.75 (0.51, 1.11) | Payen et al. 2009 [16] | 20 | 37 | 17 | 39 | 38.0% | 1.24 (0.78, 1.97) | J. Yang and H. Yang 2008 [13] | 1 | 31 | 6 | 27 | 14.7% | 0.15 (0.02, 1.13) | Peng et al. 2008 [14] | 0 | 17 | 2 | 15 | 6.1% | 0.18 (0.01, 3.43) | Yang et al. 2004 [11] | 4 | 22 | 5 | 15 | 13.7% | 0.55 (0.17, 1.70) | Subtotal (95%Cl) | | 120 | | 109 | 100.0% | 0.78 (0.57, 1.08) | Total events | 34 | | 42 | | | | Heterogeneity: Chi-square = 7.73, df = 4 ( = 0.10); = 48% | | | | | | | Test for overall effect: = 1.49 ( = 0.14) | | | | | | | Test for subgroup differences: Chi-square = 0.63, df = 1 ( = 0.43), = 0% | | | | | | |
|
|